*NURSING > QUESTIONS & ANSWERS > NR 565 WK6_Asthma_assignment_Student_Version with Asthma Case Study| all you need (All)

NR 565 WK6_Asthma_assignment_Student_Version with Asthma Case Study| all you need

Document Content and Description Below

NR565 WK 6 Asthma 1 Asthma Treatment Algorithm: To successfully treat asthma, you must first classify it and then be familiar with step therapy. For this assignment and in this course, we will focu... s on patients 12 years and older. Complete the blanks in the following table to create an algorithm for asthma care using your textbook as well as GINA guidelines . Step Asthma Classificatio n Asthma symptoms and frequency as noted in textbook Controller and Preferred Reliever: (Drug Class and frequency if provided from GINA guidelines) Controller and Alternative Reliever: (Drug Class and frequency if provided from GINA guidelines) Step 1 Intermittent Daytime symptoms 2 d/wk or less Drug class: Low dose ICSformoterol Frequency: As-needed Drug class: Take ICS Nighttime Frequency: when SABA is taken awakenings 2 times/month or less Step 2 Mild Persistent Daytime symptoms More than 2 d/wk but less than daily Drug class: Low dose maintence ICS Nighttime awakenings 3–4 times/month Step 3 Moderate Persistent Daytime symptoms Daily Drug class: Low dose maintenance ICSformoterol Drug class: Low dose maintence ICS-LABA Nighttime awakenings More than once/week but less than nightly Step 4-5 Severe Persistent Daytime symptoms Several time daily Step 4: Drug class: Medium dose maintenance ICS-formoterol Drug class: High/medium dose ICS-LABA Nighttime awakenings Often nightly Step 5: Drug class: Add LAMA, & consider high dose ICS-formoterol Refer for: phenotypic assessment, No change. This study source was downloaded by 100000834091502 from CourseHero.com on 11-16-2022 19:28:03 GMT -06:00 NR565 WK 6 Asthma 2 +/- anti-IgE, anti-IL5/R5, anti-IL4R, & consider high dose ICSformoterol Starting treatment: Complete this section using the GINA guidelines provided. First Assess: 1. Confirm diagnosis 2. Symptom control 3. Modifiable risk factors 4. Comorbidities 5. Inhaler technique & adherance 6. Patient preference [Show More]

Last updated: 2 years ago

Preview 1 out of 16 pages

Buy Now

Instant download

We Accept: